6533b7d6fe1ef96bd1265aea

RESEARCH PRODUCT

Liver Involvement in Hodgkin's Lymphoma: Types of Injuries and Therapeutic Implications

Romeo-gabriel Mihaila

subject

Hepatitismedicine.medical_specialtyPathologyChemotherapyHemophagocytic lymphohistiocytosisbusiness.industrymedicine.medical_treatmentVanishing bile duct syndromeJaundicemedicine.diseaseHodgkin's lymphomaGastroenterology03 medical and health sciences0302 clinical medicineimmune system diseaseshemic and lymphatic diseases030220 oncology & carcinogenesisInternal medicinemedicine030211 gastroenterology & hepatologyPeliosis hepatismedicine.symptomLiver dysfunctionbusiness

description

The hepatocytolysis raises questions on following therapeutic conduct when it occurs during chemotherapy for Hodgkin's lymphoma, expression of its liver toxicity. But the onset of primary liver Hodgkin's lymphoma, including the form manifested by acute liver failure, poses even greater problems, as in the case of occurrence of vanishing bile duct syndrome - expression of a paraneoplastic syndrome, hemophagocytic lymphohistiocytosis, peliosis hepatis or association of lymphoma with infection with hepatitis viruses or human immunodeficiency virus or different autoimmune diseases. This review summarizes the clinical experience acquired on the relationship between Hodgkin's lymphoma and liver, from the point of view of clinical manifestations, used treatments and clinical evolution. Suggestions on the course of treatment in patients with Hodgkin's lymphoma and liver damage have been formulated starting from the metabolism and elimination of chemotherapy drugs and taking into account the clinical experience of published clinical trials and cases. This review is a synthesis of knowledge obtained in this field, during the time, of therapeutic possibilities and limits, and formulates potential future milestones for research.

https://doi.org/10.18052/www.scipress.com/ijppe.8.1